DexCom Inc. (DXCM)
NASDAQ: DXCM
· Real-Time Price · USD
84.56
-0.27 (-0.32%)
At close: May 23, 2025, 3:59 PM
83.20
-1.61%
After-hours: May 23, 2025, 05:55 PM EDT
-0.32% (1D)
| Bid | 77.72 |
| Market Cap | 33.16B |
| Revenue (ttm) | 4.15B |
| Net Income (ttm) | 535.2M |
| EPS (ttm) | 1.33 |
| PE Ratio (ttm) | 63.58 |
| Forward PE | 33.32 |
| Analyst | Buy |
| Ask | 91.37 |
| Volume | 1,826,732 |
| Avg. Volume (20D) | 4,431,080 |
| Open | 83.94 |
| Previous Close | 84.83 |
| Day's Range | 83.48 - 85.00 |
| 52-Week Range | 57.52 - 128.63 |
| Beta | 1.44 |
About DXCM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DXCM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DXCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-0.23%
Shares of diabetes stocks are trading lower follow...
Unlock content with
Pro Subscription
1 month ago
+0.69%
Dexcom shares are trading higher after the company received FDA clearance for its G7 15-day continuous glucose monitoring system.
